• S Cayot-Constantin, J-M Constantin, J-P Perez, P Chevallier, P Clapson, and J-E Bazin.
• Service d'anesthésie-réanimation, Hôtel-Dieu, CHU de Clermont-Ferrand, boulevard L.-Malfreyt, 63058 Clermont-Ferrand, France.
• Ann Fr Anesth Reanim. 2010 Mar 1; 29 (3): 204-8.

ObjectivesTo assess the usefulness and the feasibility to use a software supervising continuous infusion rates of drugs administered with pumps in ICU.Study DesignFollow-up of practices and inquiry in three intensive care units.MaterialGuardrails software(TM) of reassurance of the regulations of the rates of pumps (AsenaGH, Alaris).MethodsFirst, evaluation and quantification of the number of infusion-rates adjustments reaching the maximal superior limit (considered as infusion-rate-errors stopped by the software). Secondly, appreciate the acceptance by staffs to such a system by a blinded questionnaire and a quantification of the number of dataset pumps programs performed with the software.ResultsThe number of administrations started with the pumps of the study in the three services (11 beds) during the period of study was 63,069 and 42,694 of them (67.7 %) used the software. The number of potential errors of continuous infusion rates was 11, corresponding to a rate of infusion-rate errors of 26/100,000. KCl and insulin were concerned in two and five cases, respectively. Eighty percent of the nurses estimated that infusion-rate-errors were rare or exceptional but potentially harmful. Indeed, they considered that software supervising the continuous infusion rates of pumps could improve safety.ConclusionThe risk of infusion-rate-errors of drugs administered continuously with pump in ICU is rare but potentially harmful. A software that controlled the continuous infusion rates could be useful.Copyright (c) 2010 Elsevier Masson SAS. All rights reserved.

12 keywords...

hide…